This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT04849728
Brief Title: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) (NATiV3)

First Submitted : April 16, 2021
First Submitted that Met QC Criteria : April 16, 2021
First Posted : April 19, 2021

Last Update Submitted that Met QC Criteria : December 4, 2023
Last Update Posted : December 6, 2023